A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

Key Inclusion Criteria: * The duration of the index hospitalization must have been at least 3 and no more than 10 consecutive days * Must meet venous thromboembolism (VTE) risk criteria with a total modified Improve VTE Risk Score of: greater than or equal 4, or 3 with D-dimer \> 2\* upper limit of normal (ULN), or 2 with D-dimer \> 2\*ULN Key Exclusion Criteria: * Any serious bleeding within 3 months prior to randomization or occurring during index hospitalization * Serious trauma (including head trauma) within 4 weeks before randomization * History of hemorrhagic stroke at any time in the past * Any medical condition that requires chronic use of any parenteral or oral anticoagulation